European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Rahier, J.F.; Ben-Horin, S.; Chowers, Y.; Conlon, C.; De Munter, P.; D'Haens, G.; Domènech, E.; Eliakim, R.; Eser, A.; Frater, J.; Gassull, M.; Giladi, M.; Kaser, A.; Lémann, M.; Moreels, T.; Moschen, A.; Pollok, R.; Reinisch, W.; Schunter, M.; Stange, E.F.; Tilg, H.; Van Assche, G.; Viget, N.; Vucelic, B.; Walsh, A.; Weiss, G.; Yazdanpanah, Y.; Zabana, Y.; Travis, S.P.L.; Colombel, J.F.

doi:10.1016/j.crohns.2009.02.010

Public

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Published in Journal of Crohn s and Colitis • Apr 27, 2009

Authors:

J.F. Rahier

S. Ben-Horin

Y. Chowers

Abstract

The treatment of inflammatory bowel disease (IBD) has been revolutionised over the past decade by the increasing use of immunomodulators, mainly azathioprine (AZA)/6-mercaptopurine (6-MP) and methotrexate (MTX), together with the advent of biological therapy. Immunomodulators are being used more oft...

Subject

Medicine

Inflammatory bowel disease

Inflammatory Bowel Diseases

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!